EPHA3
EPHA3 (EPH receptor A3, also known as HEK, HEK4, ETK, ETK1 and TYRO4) is a receptor tyrosine kinase of the ephrin receptor subfamily. It binds membrane-bound ephrin-A ligands on neighbouring cells and regulates adhesion, cytoskeletal organisation and migration. Browse Assay Genie's current range of EPHA3 research reagents below, or read on for the biology behind the target.
EPHA3 is a receptor tyrosine kinase that binds membrane-bound ephrin family ligands on adjacent cells, giving contact-dependent bidirectional signalling into the neighbouring cells. Signalling downstream of the receptor is termed forward signalling, while signalling downstream of the ephrin ligand is termed reverse signalling. The receptor is highly promiscuous for ephrin-A ligands but binds EFNA5 preferentially. Activation by EFNA5 regulates cell-cell adhesion, cytoskeletal organisation and cell migration.
EPHA3 is also activated by EFNA1, which inhibits epithelial-to-mesenchymal transition of cardiac cells and contributes to heart development. The receptor is involved in the retinotectal mapping of neurons, and it may control the segregation, but not the guidance, of motor and sensory axons during neuromuscular circuit development. This fits the wider view that EPH and EPH-related receptors mediate developmental events, particularly in the nervous system.
The EPHA3 gene belongs to the protein kinase superfamily, Tyr protein kinase family, ephrin receptor subfamily, and HGNC places it among the EPH receptors and the sterile alpha motif domain containing genes. Receptors of this subfamily typically have a single kinase domain and an extracellular region with a Cys-rich domain and two fibronectin type III repeats. Ephrin receptors fall into two groups according to extracellular sequence similarity and preference for ephrin-A or ephrin-B ligands; EPHA3 binds ephrin-A ligands. UniProt lists the protein at the cell membrane and as a secreted form, and two alternatively spliced transcript variants have been described. The previous name is EphA3.
EPHA3 is involved in the retinotectal mapping of neurons and may control segregation of motor and sensory axons during neuromuscular circuit development.
Activation of EPHA3 by EFNA1 inhibits epithelial-to-mesenchymal transition of cardiac cells and contributes to heart development.
Activated by EFNA5, EPHA3 regulates cell-cell adhesion, cytoskeletal organisation and cell migration, making it relevant to contact-dependent signalling studies.
As a promiscuous ephrin-A receptor, EPHA3 is a model for studying bidirectional signalling between neighbouring cells.
EPHA3 is a receptor tyrosine kinase that binds ephrin ligands on adjacent cells, preferentially EFNA5. Its activation regulates cell-cell adhesion, cytoskeletal organisation and cell migration, and it contributes to retinotectal mapping and, via EFNA1, to heart development.
EPHA3 is also known as HEK, HEK4, ETK, ETK1 and TYRO4, and its previous name was EphA3. HGNC names it EPH receptor A3, and UniProt calls it ephrin type-A receptor 3. Two alternatively spliced transcript variants have been described for the gene.
Yes. Mouse and rat both have an Epha3 ortholog of the human gene. The ephrin receptor subfamily as a whole is linked to developmental events, particularly in the nervous system. Check the datasheet of any product for its validated reactivity.
Other EPH receptor A family members and ephrin-binding receptor tyrosine kinases with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P29320; product specifications from Assay Genie datasheets.